“The ProMRI Study and subsequent FDA approvals have been part of a consistent and methodical process for making more MRI options available for U.S. cardiac device patients, starting with single- and dual-chamber pacemakers with an exclusion zone in May 2014, then full-body for the same pacemaker lines in March 2015, and now ICDs for full-body scans, including BIOTRONIK’s unique DX device system. This is meaningful technology that will enhance the quality of healthcare for patients throughout their lives,” Marlou Janssen added.
In addition to ProMRI technology, the newly approved devices include other features unique to BIOTRONIK devices:
Ad Statistics
Times Displayed: 19090
Times Visited: 362 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Closed Loop Stimulation (CLS), BIOTRONIK’s proprietary rate response algorithm that allows patients to receive the most physiologic pacing adaptation in accordance with their metabolic needs.
DX technology is based on more than a decade of engineering refinement to ensure accurate and reliable sensing and processing of the atrial signal. Due to its unique technology, the DX System has continued to drive BIOTRONIK’s U.S. customer adoption since it was initially introduced in February 2013.
BIOTRONIK Home Monitoring® offers the highest patient compliance2 and has demonstrated mortality reduction for patients with heart failure3.
BIOTRONIK ProMRI ICD family is equipped with competitive battery capacity to offer longevity leadership even with energy-consuming processes active4.
About ProMRI
BIOTRONIK ProMRI technology enables patients with a pacemaker, implantable defibrillator or cardiac monitor to undergo an MRI scan. Internationally, BIOTRONIK has the broadest portfolio of cardiac devices approved for use in the MR environment on the market. For more details, please go to www.biotronik.com/promri.
References
1Roguin A, et al. Europace. 2008; 10(3).
2Varma N, et al. Circ: Arrhythmia Electrophysiology. 2010 Oct;3(5)
3Hindricks G. et al. The Lancet. 2014, 384(9943).
4Data on file.
For more information, visit: www.biotronikusa.com
Contacts
Contact U.S.:
BIOTRONIK, Inc.
Carol Barbre, 800-547-0394, Ext. 8203
503-451-8203
Vice President, Marketing & Communications
carol.barbre@biotronik.com
Back to HCB News
